Cleared Traditional

K965214 - COEUR FRONT LOAD INJECTOR RETROFIT KIT (C859-0002)

K965214 is an FDA 510(k) clearance for COEUR FRONT LOAD INJECTOR RETROFIT KIT ..., manufactured by Coeur Laboratories, Inc.. The device is a Class 2 Cardiovascular device with product code DTX cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K965214 · Coeur Laboratories, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1997
Decision
88d
Days
Class 2
Risk

K965214 is an FDA 510(k) clearance for the COEUR FRONT LOAD INJECTOR RETROFIT KIT (C859-0002). Classified as Gas Control Unit, Cardiopulmonary Bypass (product code DTX), Class II - Special Controls.

Submitted by Coeur Laboratories, Inc. (Raleigh, US). The FDA issued a Cleared decision on March 28, 1997 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Coeur Laboratories, Inc. devices

FDA 510(k) Submission Details - K965214

510(k) Number K965214 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 30, 1996
Decision Date March 28, 1997
Days to Decision 88 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 125d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DTX Device Classification - Class 2, Special Controls

Product Code DTX Gas Control Unit, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DTX Gas Control Unit, Cardiopulmonary Bypass

All 9
Devices cleared under the same product code (DTX) and FDA review panel - the closest regulatory comparables to K965214.
Quantum Ventilation Module
K181942 · Spectrum Medical , Ltd. · Oct 2018
STOCKERT S5 SYSTEM AND GAS BLENDER AND SORIN C5 SYSTEM
K101046 · Sorin Group Deutschland GmbH · Dec 2010
SECHRIST AIR/OXYGEN MIXER, MODEL 3500 CP-G
K023745 · Sechrist Industries, Inc. · Jan 2003
MODIFIED SARNS MEMBRANE OXYGENATOR
K863902 · 3M Health Care, Sarns · Dec 1986
GAS-FLOW METER GFL 10
K822820 · Gambro, Inc. · Oct 1982
STANICOR, OMNI-STAN,MOD 333B,334A GAMMA
K792348 · Cordis Corp. · Dec 1979